InvestorsHub Logo
Followers 7
Posts 789
Boards Moderated 0
Alias Born 11/20/2003

Re: bbhuey post# 87

Sunday, 03/05/2017 10:15:55 PM

Sunday, March 05, 2017 10:15:55 PM

Post# of 428
Someone posted that a review of 60 small biotechs public companies that completed phase 2 trials for their drugs the median market cap was valued at $412M the mean market cap was $230M.
It is interesting that Portages 35 percent interest. in Biohaven with several phase d2 or better drugs that have orphan status is valued for much less.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRTG News